262 related articles for article (PubMed ID: 10085130)
1. ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.
Worthylake R; Opresko LK; Wiley HS
J Biol Chem; 1999 Mar; 274(13):8865-74. PubMed ID: 10085130
[TBL] [Abstract][Full Text] [Related]
2. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
[TBL] [Abstract][Full Text] [Related]
3. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
4. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK
J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938
[TBL] [Abstract][Full Text] [Related]
5. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
[TBL] [Abstract][Full Text] [Related]
6. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
[TBL] [Abstract][Full Text] [Related]
7. Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway.
Repetto E; Yoon IS; Zheng H; Kang DE
J Biol Chem; 2007 Oct; 282(43):31504-16. PubMed ID: 17716970
[TBL] [Abstract][Full Text] [Related]
8. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor.
Wiley HS; Herbst JJ; Walsh BJ; Lauffenburger DA; Rosenfeld MG; Gill GN
J Biol Chem; 1991 Jun; 266(17):11083-94. PubMed ID: 1645724
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis.
Grandal MV; Madshus IH
J Cell Mol Med; 2008; 12(5A):1527-34. PubMed ID: 18318691
[TBL] [Abstract][Full Text] [Related]
10. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.
Hendriks BS; Orr G; Wells A; Wiley HS; Lauffenburger DA
J Biol Chem; 2005 Feb; 280(7):6157-69. PubMed ID: 15572377
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.
Deb TB; Coticchia CM; Barndt R; Zuo H; Dickson RB; Johnson MD
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C365-77. PubMed ID: 18562482
[TBL] [Abstract][Full Text] [Related]
12. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
13. Enhanced degradation of EGF receptors by a sorting nexin, SNX1.
Kurten RC; Cadena DL; Gill GN
Science; 1996 May; 272(5264):1008-10. PubMed ID: 8638121
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
16. Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.
Tanaka T; Zhou Y; Ozawa T; Okizono R; Banba A; Yamamura T; Oga E; Muraguchi A; Sakurai H
J Biol Chem; 2018 Feb; 293(7):2288-2301. PubMed ID: 29255092
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
18. Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.
O'Rourke DM; Qian X; Zhang HT; Davis JG; Nute E; Meinkoth J; Greene MI
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3250-5. PubMed ID: 9096379
[TBL] [Abstract][Full Text] [Related]
19. The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2.
Zeineldin R; Ning Y; Hudson LG
J Histochem Cytochem; 2010 Jun; 58(6):529-41. PubMed ID: 20159766
[TBL] [Abstract][Full Text] [Related]
20. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
